In mouse models with AD-like pathology, decreased levels of neurotoxic amyloid Aβ peptides upon ROCK inhibition have been attributed to disruption of amyloidogenic processing of the amyloid precursor protein APP by the β-secretase BACE [58]. This evidence concerns the gene APP and Alzheimer disease.